This study addresses the pressing clinical question of optimizing surgical and pharmacological interventions for severe Carpal Tunnel Syndrome (CTS), a prevalent and debilitating condition caused by median nerve compression. Previous research has established the efficacy of Open Carpal Tunnel Release (OCTR) and Endoscopic Carpal Tunnel Release (ECTR); however, the role of neurotrophic supplementation in enhancing surgical outcomes has yet to be fully elucidated. Using a prospective clinical approach involving 497 patients, we evaluated the comparative outcomes of ECTR and OCTR with or without neurotrophic supplementation. Key findings demonstrate that ECTR, particularly when combined with neurotrophic agents, facilitates faster recovery and greater improvements in Sensory Nerve Conduction Velocity (VCS) and Visual Analog Scale (VAS) scores, with reduced complication rates compared to OCTR
Study Type
OBSERVATIONAL
Enrollment
497
Release of carpal tunnel with endoscopic device
Release of carpal tunnel with open tecnique
Neurotrophic supplementation after surgery
Policlinico di Bari
Bari, Italy, Italy
SCV evaluation
SCV will be evaluated through electomyography after ECTR or OCTR with or without neurotrophic supplementation
Time frame: 12 months of follow-up
VAS for pain evaluation
VAS for pain will be evaluated through questionnarie after ECTR or OCTR with or without neurotrophic supplementation
Time frame: 12 months of follow-up
VAS for funcionality evaluation
VAS for functionality will be evaluated through questionnarie after ECTR or OCTR with or without neurotrophic supplementation
Time frame: 12 months of follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.